Company Search:
Advanced Search
Sponsored Links
BioPorto A/S Company Snapshot
BioPorto A/S operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioPorto A/S with three other pharmaceutical manufacturers in Europe: Swedencare AB (publ) of Sweden (2015 sales of 26.83 million Swedish Kronor [US$3.01 million] ), Premier Veterinary Group PLC of the United Kingdom (£2.25 million [US$2.75 million] of which 53% was Buying group), and Enzymatica AB (publ) which is based in Sweden (27.91 million Swedish Kronor [US$3.13 million] ).

Sales Analysis. BioPorto A/S reported sales of 20.38 million Danish Kroner (US$2.98 million) for the year ending December of 2015. This represents an increase of 9.0% versus 2014, when the company's sales were 18.71 million Danish Kroner.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioPorto A/S
  Stock Performance Chart for BioPorto A/S
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 2.02
(Figures in Danish Kroner)
1 Week 2.5%   13 Weeks 6.9%  
4 Weeks -17.6%   52 Weeks -27.1%  
BioPorto A/S Key Data:
  Ticker: BIOPOR Country: Denmark
  Exchanges: CPH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 20,383,000
(Year Ending Jan 2016).
Employees: 22
  Currency: Danish Kroner Market Cap: 261,763,639
  Fiscal Yr Ends: December Shares Outstanding: 129,585,960
  Share Type: B Aktie Closely Held Shares: 33,047,735
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.